Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC
NCT04416633 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-11-08
Summary
A prospective, multicenter, Phase-IV clinical trial to assess safety of Durvalumab in Indian adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC)
Conditions
- Unresectable Non-small Cell Lung Cancer (NSCLC)
Interventions
- DRUG
-
500-mg/120-mg IV
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-30
- Primary Completion
- 2023-10-27
- Completion
- 2023-10-27
Countries
- India
Study Locations
More Related Trials
-
A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
NCT03693300 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
NCT03706690 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)
NCT04255836 ·Status: UNKNOWN ·Phase: PHASE2
-
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax
NCT05617963 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients
NCT03453307 ·Status: UNKNOWN
-
Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy
NCT04249362 ·Status: COMPLETED ·Phase: PHASE2
-
A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil
NCT06008353 ·Status: ACTIVE_NOT_RECRUITING
-
A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients
NCT02879617 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy in Patient With Poor General Condition
NCT04108026 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT00022022 ·Status: UNKNOWN ·Phase: PHASE3
-
1st Line Durvalumab in PS 2 NSCLC Patients
NCT03620669 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
NCT05221840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
NCT03819465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects
NCT04361825 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients
NCT04470674 ·Status: WITHDRAWN ·Phase: PHASE2
-
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
NCT03822351 ·Status: COMPLETED ·Phase: PHASE2
-
Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC
NCT04163432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
NCT07149363 ·Status: RECRUITING ·Phase: PHASE2
-
Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC
NCT04441138 ·Status: TERMINATED ·Phase: PHASE2
-
REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER
NCT06826677 ·Status: COMPLETED
-
Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers
NCT04230408 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC
NCT04023617 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
NCT03472053 ·Status: COMPLETED ·Phase: PHASE2
-
Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)
NCT03446547 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
NCT01160601 ·Status: COMPLETED ·Phase: PHASE2